STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Files An 8-K Submission of Matters to a Vote of Security Holders

STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Files An 8-K Submission of Matters to a Vote of Security Holders

Story continues below

ITEM 5.07

SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
On March 29, 2017, STRATA Skin Sciences, Inc. (the “Company”)
held a Special meeting of stockholders (the “Special
Shareholders’ Meeting”). The matters voted upon were:
(1) Approval of an amendment to our Fifth Amended and Restated
Certificate of Incorporation effecting a reverse stock split of
our common stock, par value $0.001 per share, at a specific ratio
within a range from 1-for-2 to 1-for-10 and to grant
authorization to the Board of Directors to determine, at its
discretion, the timing and the specific ratio of the reverse
stock split (the “Reverse Stock Split Proposal”); and
(2) Approval of a proposal to adjourn the Special Meeting to
solicit additional proxies to vote in favor of the Reverse Stock
Split Proposal (the “Adjournment Proposal”).
The results of the voting for each proposal were as follows:
(1) The Reverse Stock Split Proposal was approved.
Votes For
Votes Against
Abstain
7,289,604
816,360
54,356
There were 0 broker non-votes for this proposal.
(2) The Adjournment Proposal was approved
Votes For
Votes Against
Abstain
7,262,707
830,727
63,090
There were 0 broker non-votes for this proposal.


About STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN)

STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company’s technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.

STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) Recent Trading Information

STRATA SKIN SCIENCES, INC. (NASDAQ:SSKN) closed its last trading session up +0.005 at 0.620 with 12,942 shares trading hands.

An ad to help with our costs